Articles Published in 2007

eClinical Technology News

Wednesday, December 26, 2007 06:54 AM

• New York, N.Y.-based Medidata Solutions electronic data capture (EDC) won an agreement with Boston, Mass.-based CRO Parexel through the Medidata’s non-exclusive service provider model, ASPire to win. Medidata stated the CRO was attracted to Rave’s broad user acceptance, ease of deployment and real-time access to clinical data. Medidata Solutions also landed a contract with Dublin-based Elan Pharmaceuticals for the technology company’s Medidata Rave solution. Medidata stated that much of Elan’s data management operations is outsourced so it needed a product that could be easily adopted by any CRO regardless of past experience with the technology. Elan will use the solution for mid-to-late stage trials in North America.

More... »

AAHRPP Accredits Final Batch of Organizations for 2007

Thursday, December 20, 2007 01:21 PM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited its final 11 organizations for the year.

More... »

CenterWatch Monthly December 2007 Issue

Monday, December 17, 2007 09:58 AM

Asia-Pacific Countries Set for Global Clinical Project Leadership

More... »

Recent Industry Personnel Changes

Monday, December 17, 2007 07:57 AM

Contract Research

More... »

CWWeekly December 10th 2007 Issue

Friday, December 14, 2007 09:51 AM

Top News

More... »

PRA International Completes Buyout

Thursday, December 13, 2007 12:58 PM

Genstar Capital, a private equity group based in San Francisco, has completed its acquisition of PRA International, paying $797 million for the Raleigh, N.C.-based contract research organization (CRO).

More... »

Premier Consolidates Expertise into One Consulting Unit

Wednesday, December 12, 2007 11:37 AM

Philadelphia, Penn.-based Premier Research Group has consolidated its experts, including therapeutic leadership, medical device development, adaptive clinical trials design, and clinical trial informatics, into a single consulting group called Strategic Product Development (SPD) that will be led by Samer Kaba,M.D., vice president of SPD and global medical affairs.

More... »

ClinTech Relocates To Scotland

Tuesday, December 11, 2007 06:21 AM

ClinTec International, a CRO based in the UK, is moving it global headquarters to Scotland from its current offices in Windsor. The office will be in Glasgow, Scotland.

More... »

CWWeekly December 3rd 2007 Issue

Friday, December 7, 2007 03:10 PM

Top News

More... »

Platelet Growth Factor Hits Endpoints in Phase II

Tuesday, December 4, 2007 07:24 AM

GlaxoSmithKline reported positive results from two phase II trials of Promacta -- a non-peptide thrombopoietin receptor agonist (platelet growth factor) which can stimulate the growth and differentiation of bone marrow cells that priduce blood platelets -- for the treatment of chronic hepatitis C-associated thrombocytopenia and chronic Idiopathic thrombocytopenic purpura (ITP). The first study was an international, multicenter, double-blind, randomized, placebo-controlled, dose-ranging study. A total of seventy-four HCV-infected subjects with platelet counts between 20,000 and 70,000/mL were enrolled. The subjects received Promacta (30mg, 50mg, or 75mg daily) or placebo for four weeks (pre-antiviral phase).

More... »